Price range: $79.00 through $319.00
USD
Research Use Only (RUO) • Not for Human or Veterinary Use • Not for Consumption.
Tirzepatide Research Peptide (TIRZ) is a high-purity, lyophilized research peptide supplied for qualified laboratory use only. Peptides Skin offers Tirzepatide research peptide in multiple vial options, including 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 60 mg, and 100 mg, with ≥99% HPLC purity context, COA support, and USA-based fulfillment.
Commonly referenced as LY3298176, Tirzepatide is studied in non-clinical research contexts as a dual GIP / GLP-1 receptor agonist for receptor signaling, incretin pathway research, peptide identity review, structure–activity relationship research, and analytical laboratory workflows.
Research Use Only (RUO): This product is not for human consumption, veterinary use, injection, treatment, diagnosis, clinical use, food use, cosmetic use, or household use.
Peptides Skin supplies Tirzepatide Research Peptide (TIRZ) for qualified laboratories, procurement teams, and scientific institutions seeking a reliable USA-based research peptide supplier. This product is positioned for non-clinical research workflows where product identity, HPLC purity context, batch traceability, COA support, and RUO-only compliance are important.
Researchers reviewing Tirzepatide peptide suppliers should evaluate more than price alone. A stronger procurement review should consider product labeling, lot-specific documentation, analytical clarity, HPLC purity reporting, storage conditions, shipping reliability, and whether the supplier clearly separates research materials from human-use or veterinary-use claims.
Vial size selection should be based on laboratory inventory planning, analytical workflow requirements, and institutional SOPs. Peptides Skin does not provide human-use dosing, administration, injection, reconstitution-for-use, or treatment guidance.
Tirzepatide is a synthetic peptide compound commonly described in scientific and supplier documentation as a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R). In controlled laboratory environments, Tirzepatide may be used as a reference peptide for studying receptor-mediated biochemical signaling, incretin pathway models, peptide identity, and structure–activity relationships.
Tirzepatide differs from single-pathway GLP-1 research compounds because it is commonly studied in relation to both GIP and GLP-1 receptor pathways. This dual-pathway profile makes it relevant for non-clinical research involving receptor selectivity, comparative incretin signaling, pathway interaction models, and analytical peptide evaluation.
Tirzepatide may appear in research and procurement documentation under several related identity terms, including Tirzepatide Research Peptide, TIRZ peptide, LY3298176, and dual GIP / GLP-1 receptor agonist. These identifiers help qualified buyers compare product labeling, COA documentation, and lot-specific analytical records.
A responsible Tirzepatide research peptide review should not rely on a product name or headline purity claim alone. Qualified buyers should review product identity, lot traceability, HPLC purity context, available COA support, analytical method clarity, and whether documentation corresponds to the exact batch under review.
High-performance liquid chromatography, commonly written as HPLC, is widely used in peptide quality review to assess purity. Tirzepatide Research Peptide from Peptides Skin is presented with ≥99% HPLC purity context, and buyers may request or review analytical documentation where available for qualified research evaluation.
A Certificate of Analysis, or COA, helps laboratories review whether a batch has documentation connected to product identity, lot number, purity reporting, and analytical method context. Peptides Skin provides COA and analytical documentation support for qualified research buyers.
When available, identity-focused analytical data such as mass spectrometry or LC-MS documentation can strengthen a research buyer’s review of Tirzepatide peptide identity. HPLC purity and identity confirmation should be reviewed together, because purity percentage alone does not fully describe product identity, lot traceability, or documentation quality.
Peptides Skin is a USA-based research peptide supplier focused on laboratory research materials, product clarity, and research-only compliance. Tirzepatide Research Peptide is offered for qualified research organizations that require clear labeling, reliable fulfillment, and documentation support.
For repeat research buyers, traceability matters. A stronger procurement review compares the current Tirzepatide lot against available COA support, previous lot records, product labeling, and internal laboratory documentation standards. Repeat buyers should evaluate documentation continuity instead of relying on product name familiarity alone.
Before approving any research peptide lot, qualified buyers should confirm that product identity, lot reference, HPLC purity context, and available COA support align with the material being reviewed.
Within controlled in-vitro and non-clinical laboratory environments, Tirzepatide Research Peptide is commonly referenced in studies and analytical workflows involving dual incretin receptor research, peptide identity, receptor signaling, and comparative pathway models.
These references are provided for laboratory research context only. This product is not intended for clinical use, diagnostic use, therapeutic use, human consumption, veterinary use, injection, or administration to any living subject.
Tirzepatide is frequently referenced as a research chemical in laboratory and analytical research environments. In non-clinical research models, scientists may evaluate Tirzepatide in relation to dual GIP / GLP-1 receptor signaling, peptide stability, analytical identity, and structure–activity relationships.
All applications involving Tirzepatide as a research chemical must be conducted strictly under controlled laboratory conditions by qualified personnel. Peptides Skin supplies this material strictly as a research-use-only laboratory product.
| Product Name | Tirzepatide Research Peptide |
| Common Name | TIRZ peptide |
| Research Identifier | LY3298176 |
| CAS Number | 2023788-19-2 |
| Research Category | Dual GIP / GLP-1 receptor agonist research peptide |
| Available Vial Options | 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 60 mg, 100 mg |
| Form | Lyophilized powder |
| Purity Context | ≥99% HPLC purity context |
| Documentation | COA and analytical documentation support available |
| Grade | Research grade |
| Use | Research Use Only (RUO) |
| Parameter | Specification |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | Approximately 4813.5 g/mol |
| Appearance | White to off-white lyophilized powder |
| Purity Context | ≥99% HPLC purity support |
| Documentation | COA support available for qualified research review |
| Intended Use | In-vitro and non-clinical research use only |
Tirzepatide Research Peptide is supplied in lyophilized powder form to support laboratory storage and handling. Unopened vials should be stored in a cool, dry, and light-protected environment according to institutional SOPs, supplier documentation, and applicable laboratory quality procedures.
Handling, reconstitution, aliquoting, and storage decisions should be made only by qualified laboratory personnel following validated internal procedures. For broader RUO handling context, review the RUO lyophilized peptide handling guide.
Peptides Skin does not provide human-use, veterinary-use, injection, treatment, diagnostic, administration, or dosing instructions.
When evaluating Tirzepatide peptide suppliers, qualified buyers should compare documentation quality, batch traceability, HPLC reporting, COA clarity, product identity, and supplier compliance language. A low price or high purity number should not be the only basis for supplier review.
For research procurement, the strongest supplier review starts with documentation. Buyers should review product identity, lot traceability, HPLC purity context, COA support, and research-only compliance before approving a material for internal laboratory workflows.
For additional research-only buying and documentation context, review these Peptides Skin resources:
Tirzepatide Research Peptide is a synthetic research peptide used in qualified non-clinical laboratory environments to study dual GIP and GLP-1 receptor signaling pathways, peptide identity, analytical quality, and related biochemical research models.
TIRZ peptide is a common abbreviated reference for Tirzepatide Research Peptide. Buyers may see TIRZ used in product labels, variant names, collection pages, and laboratory documentation.
LY3298176 is a commonly referenced research identifier associated with Tirzepatide. It may appear in research, analytical, and supplier documentation when reviewing product identity.
Yes. Tirzepatide is commonly described in research contexts as a dual GIP / GLP-1 receptor agonist. This makes it relevant for laboratory studies involving incretin receptor pathways and comparative receptor signaling models.
The commonly referenced CAS number for Tirzepatide is 2023788-19-2. Qualified buyers should confirm technical identifiers against supplier documentation and batch-specific records when available.
Yes. COA support and analytical documentation are available for qualified research review. Buyers should confirm that documentation matches the specific lot or batch being evaluated.
Tirzepatide Research Peptide is supplied with ≥99% HPLC purity context. Purity should be reviewed together with product identity, lot reference, method context, COA support, and available analytical documentation.
No. HPLC purity is important, but a stronger review also considers product identity, lot traceability, COA clarity, analytical method context, and whether documentation matches the batch being reviewed.
Yes. Tirzepatide Research Peptide is supplied as a lyophilized powder in sealed research vials for qualified laboratory use only.
Unopened lyophilized vials should be stored in a cool, dry, and light-protected environment according to institutional laboratory SOPs and product documentation. Qualified labs should follow their own validated storage and handling procedures.
Yes. Qualified research organizations may purchase Tirzepatide Research Peptide from Peptides Skin for legitimate in-vitro and non-clinical research use only.
No. This product is a research-use-only laboratory material. It is not a prescription medication, not a compounded drug product, not for human use, not for veterinary use, and not intended to diagnose, treat, cure, or prevent any disease.
No. Peptides Skin does not provide dosing, injection, administration, medical, veterinary, treatment, or diagnostic guidance. This product is sold strictly for research use only.
This product is sold strictly for Research Use Only (RUO). It is not intended for human consumption, veterinary use, medical treatment, diagnostic use, clinical use, injection, or use in food, drugs, cosmetics, or household products. Buyers are responsible for compliance with all applicable laws, regulations, institutional policies, and laboratory safety requirements.
